Resting energy expenditure (REE) is the amount of energy required for maintaining normal body functions, such as cardiovascular, brain and cell function, over a 24-h period at rest(1). REE is estimated either via direct or indirect calorimetry or using available predictive equations(Reference Alastair, Emma and Emma2,Reference Kushner and Schoeller3) . In the clinical practice, REE is widely predicted based on several equations that are available in the literature(Reference Forbes, Escher and Hebuterne4).
Crohn’s disease (CD) is an inflammatory bowel disease characterised by alterations of REE mainly due to the presence of active inflammation(Reference Alastair, Emma and Emma2). Patients with active disease usually experience an increase in their REE compared with patients in remission(Reference Alastair, Emma and Emma2,Reference Kushner and Schoeller3) . However, inconsistent data were observed among available studies regarding REE and disease activity(Reference Forbes, Escher and Hebuterne4). Possible explanations for this might be an altered body composition due to inflammation (mostly a decrease in fat-free mass (FFM) and an increase in fat mass), drugs (especially corticosteroids) and lower levels of physical activity especially during the acute phases of the disease(Reference Forbes, Escher and Hebuterne4–Reference Rocha, Santana and Almeida7). Studies exploring the accuracy of several predictive equations in patients with CD are scarce and rather old with only three studies examining the use of Harris–Benedict equations in patients with CD(Reference Stokes and Hill8–Reference Capristo, Addolorato and Mingrone10). According to their findings, predicted REE (pREE) did not differ from measured REE (mREE) irrespectively from disease activity. Based on these limited results, the European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines, published in 2017, mentions that predictive equations are suitable for these patients, since no consistent associations have been found between REE and disease activity and indirect calorimetry should be used in troublesome cases(Reference Forbes, Escher and Hebuterne4).
However, the abovementioned studies exhibit several methodological limitations such as small sample sizes and different ways of REE estimation(Reference Stokes and Hill8–Reference Capristo, Addolorato and Mingrone10), whereas they have used current body weight for the calculation of REE and there are not available studies examining whether use of adjusted body weight for obese patients could improve accuracy of REE. In addition, the accuracy of predictive equations including body composition parameters has not been yet explored. Acknowledging some of these limitations, Marra et al.(Reference Marra, Cioffi and Morlino11) recently examined the accuracy of several predictive equations in patients with CD and found that most of them underestimate REE leading them to the development of new disease-specific equations for this population. However, the reliability of these equations has not been explored yet(Reference Marra, Cioffi and Morlino11).
Recognising the limitations of utility of indirect calorimetry in clinical settings and the need for accurate prediction of REE in patients with CD, the aim of the present study was to investigate the accuracy of widely used REE predictive equations in patients with CD against REE measurement through indirect calorimetry. Additional exploratory aim was to estimate the accuracy of these equations according to disease activity, sex, medication use, BMI categories and body weight used in the predictive equations.
Materials and methods
Study sample
The study sample consisted of outpatients with CD participating in a cross-sectional nutritional status evaluation study. Inclusion criteria included patients > 16 years, with confirmed CD for more than 6 months and without previous history of cancer. All patients were enrolled from three outpatient gastroenterology clinics (Department of Gastroenterology, ‘Evangelismos-Ophthalmiatreio Athinon-Polykliniki’ General Hospital of Athens, Department of Gastroenterology, General Hospital of Nikaia Piraeus ‘Agios Panteleimon’-General Hospital Dytikis Attikis ‘Agia Varvara’ and GI-Unit, 3rd Academic Department of Internal Medicine, ‘Sotiria’ Hospital of Athens) from November 2018 to November 2019. Diagnosis was based on biopsy and a combination of clinical, histological, endoscopical, imaging and biochemical data. Exclusion criteria included hospitalised patients, patients with CD for less than 6 months, < 16 years old, with short bowel syndrome, cancer or history of cancer, chronic heart or kidney disease, nutrition support (parenteral nutrition) and for females, a period of gestation and lactation. For the current analyses, further exclusion criteria included not following instructions for REE measurement (i.e. overnight fasting for 12 h, avoid physical activity for 48 h and smoking the day of the test) and patients following a specific weight loss diet for more than 2 weeks.
Ethical approval
The study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human patients were approved by the Bioethics Committee of Harokopio University, the Scientific Committees of the three participating hospitals and were registered in ClinicalTrials.gov (NCT03871634). Written informed consent was obtained from all patients.
Medical assessment
Data regarding basic socio-demographic characteristics (education level, marital status), smoking status, co-morbidities and medical treatment were recorded from collaborating physicians during medical assessment. Montreal classification was used for the categorisation of patients according to age at diagnosis (< 16, 17–40, > 40 years), disease location (ileal, colonic, ileocolonic) and behaviour (non-structuring/non-penetrating, structuring, penetrating)(Reference Silverberg, Satsangi and Ahmad12). Clinical manifestations, such as abdominal pain, diarrhoea, blood loss, fever, weight loss and extra-intestinal manifestations, as well as their severity were also recorded. Disease activity was evaluated by endoscopy and using the Harvey–Bradshaw Index (HBI)(Reference Harvey and Bradshaw13). Patients with HBI < 5 and normal C-reactive protein levels (< 5 mg/l)(Reference Colombel, DʼHaens and Lee14) were categorised as in remission.
Anthropometry and body composition
Body weight was measured to the nearest 0·1 kg and body height to the nearest 0·1 cm using a Seca 770 analogue body scale and stadiometer (Seca Alpha, Model 770). Subjects were instructed to wear light clothes and were measured without shoes. BMI was calculated dividing weight (in kg) by the square of height (in meters)(Reference Garrow and Webster15). Body composition analysis was performed using the dual X-ray absorptiometry method (Lunar DPX-MD; Lunar Corp.).
Resting energy expenditure
REE was measured via indirect calorimetry using a mouthpiece and nose-clip system (Ultima™ Series PFX® with GC, MedGraphics Cardiorespiratory Diagnostics Corporation) for about 20–30 min. Calibration was conducted before each measurement using a gas mixture with known concentrations of oxygen analyser and carbon dioxide analyser (gas 1: CO2:4 %, O2:16 %, gas 2: CO2:0 %, O2:26 %). Before REE measurement, subjects were instructed to follow an overnight fasting (only water permitted), avoid physical activity for 48 h and not smoke the day of the test. REE measurement was conducted in a quiet, temperature and humidity-controlled environment, with the subject sitting in a slight incline position for 15 min before the test. REE measurement was finished when the subject was in a steady condition at least for 5 min, as indicated by RQ, oxygen consumption and minute ventilation rate. REE was calculated using the Weir formula(Reference Peronnet and Massicotte16), without using protein oxidation(Reference Harris17).
Predictive equations
mREE from indirect calorimetry was compared with pREE from fourteen widely used predictive equations for general population. Harris–Benedict(Reference Harris17), Schofield(Reference Schofield18), FAO/WHO/UNU(19), Mifflin(Reference Mifflin, St Jeor and Hill20), Owen(Reference Owen, Holup and DʼAlessio21,Reference Owen, Kavle and Owen22) , Muller(Reference Muller, Bosy-Westphal and Klaus23) and Marra equations, specific for CD patients(Reference Marra, Cioffi and Morlino11) were tested (online Supplementary Table S1). Also, Mifflin-St. Jeor(Reference Mifflin, St Jeor and Hill20), Owen(Reference Owen, Holup and DʼAlessio21,Reference Owen, Kavle and Owen22) , Muller(Reference Muller, Bosy-Westphal and Klaus23), Huang(Reference Huang, Kormas and Steinbeck24), Wang(Reference Wang, Heshka and Gallagher25), Cunningham(Reference Cunningham26) and Johnstone(Reference Johnstone, Rance and Murison27) equations with a measure of body composition (FFM and/or fat mass) were also included (online Supplementary Table S1). For the calculations of REE from predictive equations, three different approaches for body weight were used. The first approach used current body weight for all patients with CD. The second approach used current body weight for all patients with CD except for obese patients (BMI ≥ 30 kg/m2) for whom an adjusted body weight as ((current body weight + ideal body weight)/2) was used(Reference Glynn, Greene and Winkler28). The third approach used current body weight for all patients with CD except for obese patients (BMI ≥ 30 kg/m2) for whom another formula for adjusted body weight was used, namely ((current-ideal)/4 + ideal body weight)(Reference Alves, da Rocha and Gonzalez29). Ideal body weight was calculated as the body weight corresponding to BMI 25 kg/m2 for both equations for adjusted body weight(Reference Glynn, Greene and Winkler28,Reference Alves, da Rocha and Gonzalez29) . Adjusted body weight was used for patients with obesity, since it accounts for the increased proportion of body weight as low metabolically active adipose tissue in obese people(Reference Heymsfield30). Initially, results from each predictive equation were not multiplied with a stress factor neither for active disease nor for remission.
Statistical analysis
For the needs of the current analysis, based on an error limit of prediction accuracy of 10 % between mREE and pREE(Reference Harris17,Reference Frankenfield, Roth-Yousey and Compher31) a total of ninety-five patients would be required to achieve a 90 % statistical power at a 5 % significance level (i.e. 95 % CI).
Statistical analysis was performed using IBM SPSS version 23 (IBM Corp. Released 2016. IBM SPSS Statistics for Windows, Version 24·0. IBM Corp.) and STATA version 15 (M. Psarros & Assoc.). The statistical significance threshold was set at 0·05. The normality of continuous variables was evaluated with Shapiro–Wilk test and graphically with Q-Q plots. Categorical variables were presented as relative and absolute frequencies. Data are presented as mean values and standard deviations for normally distributed variables and as median and 25th and 75th percentiles for non-normally distributed variables. Differences between active disease and remission were evaluated using independent t test or Mann–Whitney rank tests for normally and non-normally distributed continuous variables, respectively, and χ 2 tests for categorical variables. Differences between BMI categories were evaluated using one-way ANOVA (for normally distributed continuous variables) and Kruskal–Wallis test (for non-normally distributed continuous variables). Tukey’s test or multiple Mann–Whitney rank tests were used at post hoc analyses for the recognition of groups which differed significantly.
Pearson’s and Spearman’s correlation coefficients were used to test associations between mREE and pREE for normally distributed and skewed variables, accordingly. For each predictive equation, linear regression analysis was performed for the calculation of root mean square error (RMSE). Bland–Altman analysis was performed for the assessment of agreement between data from indirect calorimetry and data from each predictive equation and the estimation of the corresponding limits of agreement. Bias was calculated as average difference between pREE minus mREE, with positive values representing overpredictions of mREE and negative values underpredictions of mREE. Also, bias has been presented as a percentage of mREE. The corresponding limits of agreement were defined as bias ± 1·96 × sd. Subjects outside limits of agreement refer to patients whose bias was over 1·96 × sd or under −1·96 × sd in Bland–Altman analyses. Bias within this range is considered as acceptable(Reference Bland and Altman32), whereas bias outside this range is considered as large, meaning that the equation cannot accurately predict REE in the group level. Pearson’s or Spearman’s correlation coefficients as a measure of agreement were also calculated. A percentage of patients with CD whose pREE was within ±10 % of mREE was considered as a measure of accuracy at an individual level(Reference Frankenfield, Roth-Yousey and Compher31). At the group level, Bland–Altman method was used and plots presented the difference between pREE and mREE in the vertical axis and the mean of pREE and mREE in the horizontal axis(Reference Bland and Altman32).
Pearson’s and Spearman’s correlation coefficients were used to test associations between the variation of pREE and several predictors (i.e. BMI, weight, age, CRP, HBI, sex, fat mass and FFM) for normally distributed and skewed variables, accordingly. Variables being significantly correlated with the variation of pREE at a significance level < 0·1 were then included in multivariate linear regression models.
Results
In total, 250 patients with CD included in a cross-sectional evaluation of nutritional status were assessed for eligibility in the current analyses. Ten patients who did not have complete data, eight patients who followed a weight loss diet for more than 2 weeks and forty-six patients who did not follow instructions for REE measurement (i.e. overnight fasting, avoid physical activity for 48 h and smoking the day of the test) were excluded from the present analyses, leading to a final sample of 186 patients (Fig. 1) (102 males, mean age 41·3 (sd 14·1) years and mean BMI 27·1 (sd 5·9) kg/m2). Most of the patients were diagnosed between 17 and 40 years old (65·6 %), had ileal (48·4 %) or ileocolonic disease (41·3 %) and a small percentage of them (10·3 %) had isolated upper gastrointestinal disease. Based on BMI categories, 3·2 % of patients were underweight (BMI < 18·5 kg/m2), 32·3 % were overweight (BMI 25–29·9 kg/m2) and 27·4 % were obese (BMI ≥ 30 kg/m2). Patients’ characteristics according to disease activity are presented in Table 1. Regarding medication, patients with active disease reported more frequent use of corticosteroids, whereas the majority of patients in remission received 5-aminosalicylic acid, azathioprine and biologic agents (data not shown).
CONSORT chart. From November 2018 to November 2019, 382 patients with CD were referred by collaborating physicians for screening. Of the 382 patients, eighty-two declined to participate, twenty-eight did not show up for the assessments and twenty-two were diagnosed with CD for less than 6 months. In total, 250 patients with CD were included in a cross-sectional evaluation of nutritional status and assessed for eligibility in the current analyses. Ten patients who did not have complete data, eight patients who followed a weight loss diet for more than 2 weeks and forty-six patients who did not follow instructions for REE measurement (i.e. overnight fasting, avoid physical activity for 48 h and smoking the day of the test) were excluded from the present analyses, leading to a final sample of 186 patients. These patients were further classified by disease activity based on HBI to seventy patients with active CD and 116 patients in remission. CD, Crohn’s disease; HBI, Harvey–Bradshaw Index; REE, resting energy expenditure.
Descriptive characteristics of 186 patients with Crohn’s disease according to disease activity
(Mean values and standard deviations)
CRP, C-reactive protein; GI, gastrointestinal disease; FFM, fat-free mass; FM, fat mass; EBI, Harvey–Bradshaw Index.
* Fat-free mass and fat mass were measured using dual-energy X-ray absorptiometry.
† Data for continuous variables are presented as means (standard deviation) or median (and 25th–75th percentiles) and for categorical variables as absolute numbers and relative frequencies.
‡ P-values were calculated using independent t test or Mann–Whitney rank tests for normally and non-normally distributed continuous variables, respectively, and χ 2 tests for categorical variables.
Comparisons of measured resting energy expenditure with predicted resting energy expenditure for equations without body composition analysis parameters
Mean mREE in the total sample was 7255 (sd 1854) kJ/d (range: 2941–13544 kJ/d) (Table 2). mREE was compared with pREE using different approaches for body weight. All calculations based on current body weight underpredicted REE. Harris–Benedict and Marra equations were closer to mREE, while Mifflin and Owen ones showed the lowest pREE from all equations (Table 2). Also, pREE was compared with mREE graphically showing that all equations underestimated mREE (online Supplementary Fig. S1).
Evaluation of REE from predictive equations without stress factor in 186 patients with Crohn’s disease
(Mean values and standard deviations; median values and percentiles)
BW, body weight; REE, resting energy expenditure; RMSE, root mean square prediction error.
* P-values < 0·001.
† Predicted REE is considered accurate if it is within ±10 % of measured REE.
‡ Data are presented as means (standard deviation) or median (and 25th-75th percentiles).
§ Adjusted BW: (current BW + ideal BW)/2 for obese patients (BMI ≥ 30 kg/m2), current BW for underweight, normal weight and overweight patients. Ideal BW is corresponded to BMI 25 kg/m2.
When adjusted body weight for patients with BMI ≥ 30 kg/m2 was used as ((current body weight + ideal body weight)/2), predictive equations underestimated REE and difference between mREE and pREE was higher, indicating that current body weight was a better choice than adjusted body weight for calculating energy expenditure in obese patients with CD (Table 2). Calculations based on adjusted body weight for patients with BMI ≥ 30 kg/m2 estimated as ((current body weight – ideal body weight)/4 + ideal body weight) presented even larger underestimation of mREE and lower accuracy compared with other approaches for body weight and were no further explored (data not shown).
Accuracy at the individual level
When accuracy of pREE at the individual level was assessed, all predictive equations without body composition parameters showed similar results regarding correlations with mREE (Pearson’s r or Spearman’s rho 0·600–0·680 for current weight and 0·596–0·677 for adjusted weight, all P-values < 0·001, Table 2). Moderate correlations were observed when pREE was calculated with equations including body composition parameters (Pearson’s r or Spearman’s rho 0·598–0·625, all P-values < 0·001). Owen equations without body composition variables showed the worst results with less strong correlations and higher RMSE, while Harris–Benedict and Marra equations showed the best results and lower RMSE. The proportion of pREE equations within ±10 % of mREE is presented in Fig. 2. Harris–Benedict and Marra equations with current body weight showed the highest accuracy within ±10 % of mREE (42 and 41 %, respectively) (Fig. 2). However, all predictive equations without body composition analysis parameters showed low accuracy within ±10 % of mREE. More than half of the patients’ REE were not accurately predicted with existing equations. In specific, accuracy was low for all equations at the individual level (28–42 % for current body weight and 25–40 % for adjusted body weight) (Table 2).
Proportion of predictive REE equations within ±10 % of measured REE. A predictive REE equation was considered accurate if it was within ±10 % of measured REE. If accuracy was < 90 %, the predictive equation underestimated REE. If accuracy was > 110 %, the predictive equation overestimated REE. Adjusted BW: (current BW + ideal BW)/2 for obese patients (BMI ≥ 30 kg/m2), current BW for underweight, normal weight and overweight patients. Ideal BW is corresponded to BMI 25 kg/m2. BW, body weight; REE, resting energy expenditure.
Accuracy at the group level
pREE accuracy was further explored at the group level by performing the Bland–Altman analyses (Table 3, online Supplementary Fig. S2). Bias (as a percentage and as kJ/d), 95 % CI for the bias, limits of agreement and subjects outside limits of agreement are presented in Table 3. Schofield equations with current body weight showed the best accuracy at the group level (bias −0·5 %, limits of agreement −3125, 2494 kJ) followed by FAO/WHO/UNU (bias −0·97 %, limits of agreement −3163, 2473 kJ) and Marra equations, which showed the smallest limits of agreement among all equations (bias 1·69 %, limits of agreement −2929, 2565 kJ, respectively). However, correlations between difference of each pREE and mREE with mean REE were moderate (rho 0·438–0·578, all P-values < 0·001).
Bland–Altman analyses for the agreement between measured REE from indirect calorimetry and REE from predictive equations in 186 patients with Crohn’s disease
(Mean values and standard deviations)
BW, body weight; REE, resting energy expenditure.
* Spearman’s correlation coefficients between mean and difference REE from each predictive equation and REE from indirect calorimetry. All P-values < 0·001.
† Bias is defined as the mean difference between measured REE and predicted REE.
‡ Adjusted BW: (current BW + ideal BW)/2 for obese patients (BMI ≥ 30 kg/m2), current BW for underweight, normal weight and overweight patients. Ideal BW is corresponded to BMI 25 kg/m2.
Regarding adjusted body weight, Harris–Benedict equations showed the best accuracy at the group level (bias 0·82 %, limits of agreement −2933, 2473 kJ). Moderate positive correlations remained in all equations (rho = 0·562–0·655, all P-values < 0·001). Mifflin and Owen equations showed the worst results both for current and adjusted body weight at the group level (Table 3).
Comparisons of measured resting energy expenditure with predicted resting energy expenditure and accuracy at the individual and group level for equations with body composition analysis parameters
Except for equations without body composition parameters, pREE was also calculated using equations with body composition analysis parameters. All these equations yielded REE values lower than mREE and even lower than pREE from equations without body composition analysis (Table 2). Muller equations showed more closer results to mREE with lower RMSE, while Owen equations showed the worst results compared with the rest of equations based on body composition analysis parameters (Table 2).
Moreover, accuracy of these equations has been assessed at the individual level. Owen equations again showed the worst results with less strong correlations and higher RMSE, while Harris–Benedict and Marra equations showed the best results (Table 2). However, all predictive equations with body composition analysis parameters showed lower accuracy within ±10 % of mREE compared with those without body composition analysis parameters (19–33 %) (Table 2, Fig. 2).
When accuracy was assessed at the group level, all equations showed wider limits of agreement and worse results than equations without body composition parameters (Table 3, online Supplementary Fig. S2). It should be noted that all predictive equations used in the current study showed wide limits of agreement and proportional biases with the difference between pREE and mREE getting larger as mean REE was increasing.
Comparison between measured resting energy expenditure and predicted resting energy expenditure in terms of disease activity
Further sensitivity analyses were conducted to investigate whether accuracy of the predictive equations differed depending on disease activity. Mean mREE was compared with mean pREE from different equations used in the current study within and between active disease and remission. Within these groups, all predictive equations underestimated REE and showed moderate correlations with mREE (all P-values < 0·001, data not shown). Between groups, pREE and mREE did not differ (all P-values > 0·05). Worse results were observed when adjusted body weight for obese patients was used for calculations of REE predictive equations (online Supplementary Table S2).
Moreover, accuracy of pREE was further investigated at the individual (online Supplementary Table S2) and group level (online Supplementary Table S3) according to the disease activity. Based on these results, accuracy remained low (17–40 % in active disease and 19–44 % in remission) at the individual level and presented wide limits of agreement and proportional biases (0·467–0·693 in active disease and 0·447–0·645 in remission, all P-values < 0·001) at the group level according to the Bland–Altman analyses. Worse results were observed when adjusted body weight for obese patients was used for calculations of REE from all predictive equations and from REE equations with body composition analysis parameters.
Since accuracy remained low when sample was studied according to disease activity groups, different stress factors between 0 and 10 % based on the Elia graph(Reference Elia33) were applied in all predictive equations to explore any improvements of accuracy. All equations were adjusted for a stress factor either in active disease only or in active disease and remission. Although several stress factors were applied in all equations, the accuracy was not improved (data not shown).
Comparison between measured resting energy expenditure and predicted resting energy expenditure in terms of BMI categories, sex and medication use
Further exploratory analyses were performed according to BMI categories. Patients were categorised either into four BMI categories (< 18·5, 18·5–24·9, 25–29·9 and ≥ 30 kg/m2) or into five BMI categories (< 18·5, 18·5–24·9, 25–26·9, 27–29·9 and ≥ 30 kg/m2) by further dividing overweight patients into two categories based on median BMI (BMI 27 kg/m2). For both approaches, all predictive equations used in the current study tended to underestimate REE in all BMI categories, except for BMI 27–29·9 kg/m2 for Harris–Benedict, Schofield and FAO/WHO/UNU equations, which presented a trend of overestimation (data not shown). Moreover, accuracy of pREE was further investigated at the individual level according to BMI categories and results were similar with those for disease activity for all equations (all P-values > 0·05, data not shown). At the group level, accuracy remained low, with large CI and wide limits of agreement and proportional biases for all equations tested and in all BMI categories (online Supplementary Fig. S3). Regarding sex, males had higher REE compared with females and all predictive equations underestimated REE both in males and females. Moreover, according to sensitivity analyses for sex, the accuracy of pREE was low both at the individual and group level, with large CI and wide limits of agreement, as well as proportional biases for all equations tested in either sex category (data not shown). Regarding medication, several analyses were performed according to medication categories (i.e. 5-ASA, azathioprine, methotrexate, corticosteroids, biologic agents); however, results remained practically unchanged not supporting that medication could be responsible for the large bias of the pREE (data not shown).
Associations between variation of predicted resting energy expenditure and potential predictors
To further explore which parameters could have predominantly affected bias of pREE, correlations between the variation of pREE and several parameters (i.e. BMI, weight, age, CRP, HBI, sex, fat mass and FFM) were explored. BMI, CRP, HBI and sex did not correlate with the variation of pREE, whereas age, weight, fat mass and FFM did, as presented in Table 4. Those variables correlated with variation of pREE at a significance level < 0·1 were then included in multivariate models. According to the results, only age was positively correlated with variation of pREE for all equations with body composition analysis parameters and for most of those without body composition analysis parameters, except for Harris–Benedict, FAO/WHO/UNU and Mifflin with current body weight.
Correlations of resting energy expenditure variation of pREE with age, weight, fat mass and fat-free mass
BW, body weight.
* P-value < 0·001.
** P-value < 0·01.
*** P-value < 0·05.
Discussion
In the current study, the accuracy of fourteen widely used REE predictive equations was explored in CD outpatients. According to the results, all predictive equations showed low accuracy both at the individual and group level (wide limits of agreement and proportional biases) and variation of pREE was positively associated with age.
Few studies have explored the accuracy of predictive REE equations in patients with CD and most of them have explored the Harris–Benedict equations but with conflicting results, finding that these equations either accurately predicted mREE(Reference Barot, Rombeau and Feurer34) or underestimated REE(Reference Stokes and Hill8,Reference Chan, Fleming and OʼFallon9) . However, these studies had small sample sizes (< 55 patients), different inclusion criteria and methodological limitations(Reference Stokes and Hill8,Reference Chan, Fleming and OʼFallon9,Reference Barot, Rombeau and Feurer34) . In line with our results, Marra et al.(Reference Marra, Cioffi and Morlino11) also found that several equations underestimated REE in 270 CD outpatients. Moreover, all equations used in the current study could predict REE for a small proportion of patients with CD (< 40 %) within ±10 %, whereas those with body composition analysis parameters could predict even fewer patients.
Marra et al.(Reference Marra, Cioffi and Morlino11) also developed new disease-specific equations for patients with CD. In the current study, we compared these equations with mREE; however, also these equations showed low accuracy (42 %) with large negative and positive error at the individual level and wide limits of agreement (5494 kJ), and proportional biases at the group level. Although these equations are CD specific and have been suggested as to accurately predict REE of patients with CD, this was not confirmed in our study. Comparing our study with that of Marra et al., the most striking difference seems to be the weight status with our sample having mean weight 77·5 (sd 18·4) kg and mean BMI 27·1 (sd 5·9) kg/m2, whereas the validation group in the study of Marra et al. had mean weight 63·8 (sd 12·7) kg and mean BMI 21·9 (sd 3·7) kg/m2. This difference in weight status could partly explain the different results regarding accuracy of these equations at the individual level.
Since FFM affects REE, the use of predictive equations with FFM has been suggested in the past as more accurate than using equations based only on weight and height. However, in the present study, these equations underestimated REE more than equations without body composition variables and showed lower accuracy rates compared with other equations. Low accuracy of these equations may be due to the fact that FFM is a heterogeneous part of the body composition that contains tissues and organs with different metabolic responses(Reference Elia, Kinney and Tucker35). FFM explains a large percentage (up to 80 %) of REE(Reference Geisler and Müller36). In addition, accuracy of REE equations using body composition analysis parameters could also be affected by the techniques applied in the development and assessment of FFM. Most of the available REE equations have been developed using bioelectrical impedance analysis or skinfolds as methods of body composition assessment, and none has used the dual X-ray absorptiometry, the method applied in the current study.
Possible associations between variation of pREE and potential parameters that could have contributed to this bias were further explored. Age was the only variable associated with variation of pREE in multivariate models and was positively associated with it for all equations except those of Harris–Benedict, FAO/WHO/UNU and Mifflin with current body weight, suggesting that as age is increasing it is associated with REE overprediction. The decrease in REE with age is well known and could be partly attributed to decreases in FFM, in protein synthesis and norepinephrine secretion(Reference Cioffi, Marra and Pasanisi37,Reference Manini38) .
Adjusted body weight has been suggested for patients with obesity, since adipose tissue is not as metabolically active as lean tissue, so using current body weight may lead to overestimation of REE(Reference MacDonald, Moore and Davey39). Most of the available equations have been developed for healthy non-obese populations using current body weight and the use of adjusted body weight has been proposed as a way of correction of REE estimation for obese patients(Reference Frankenfield40), although it has been found that adjusted body weight often underestimates REE in obese individuals(Reference Frankenfield40,Reference Frankenfield, Rowe and Smith41) . In the present study, adjusted body weight for CD patients with BMI ≥ 30 kg/m2 was also used; however, accuracy was not improved compared with the results with current body weight.
Since all equations tested could predict REE with accuracy < 42 %, different stress factors of 0–10 % based on Elia et al.(Reference Elia33) were applied either in active disease or both in active disease and remission to explore whether accuracy could be improved. A stress factor was applied in remission, since patients with CD appear a chronic low-grade inflammation persisting in this disease activity group, resulting that patients often experience an increase in their REE not only in active disease but also in remission(Reference Moss42). However, accuracy was not improved and still presented large CI, wide limits of agreement and proportional biases. This could be partly attributed to the fact that the level of inflammation is probably different for each patient and depends on several factors, such as disease duration, location and drug therapy(Reference Moss42,Reference Sammarco, Marra and Pagano43) . Consequently, patients with CD constitute a heterogeneous population and a specific percentage for stress factor for all patients would not improve accuracy, since each patient may need or not a different stress factor based on general clinical and endoscopic evaluation.
Based on current findings, the problem of exact REE estimation remains, given that no equation seems to accurately predict energy needs of patients with CD. Based on the existing equations and data, in the clinical practice where indirect calorimetry is not always available, it is recommended to start dietary intervention using one of these predictive REE equations and reassess CD patient at regular intervals to adjust dietary intake according to actual needs.
The present study has both strengths and limitations. This is the first study examining the accuracy of different REE predictive equations with and without body composition analysis parameters using current and adjusted body weight (for equations without body composition analysis) in patients with CD and according to disease activity, sex, age groups and BMI categories. In addition, study sample included a wide range of patients with CD (i.e. active disease and in remission, different disease location), allowing results to be extracted for the whole range of patients with CD. Furthermore, mREE was assessed by the gold-standard method, namely indirect calorimetry, for at least 20–30 min ensuring that the patients were in a steady-state condition with appropriate conditions to perform the measurement. Regarding limitations, most of patients with CD were in remission and a smaller percentage (37·6 %) had active disease, whereas some sensitivity analyses performed in small subgroups (i.e. patients with BMI < 18·5 kg/m2 and patients using methotrexate) may have been underpowered.
Conclusions
All predictive equations used in the present study underestimated REE and showed low ability to accurately estimate actual resting energy needs of CD patients both at the individual and group level. Indirect calorimetry remains the best method for estimating REE of patients with CD.
Acknowledgements
The authors would like to thank Dr. Giannis Arnaoutis, Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece, for his help and administration regarding REE measurement protocol.
No funding.
M. D. K. conceived the study’s research hypothesis, objectives and design and was responsible for the supervision of research activity. A. K., M. B., E. A., G. K., E. Z. and C. V. were involved in patient recruitment and assessment, A. K. wrote up the first draft of the manuscript, performed the statistical analyses and created tables and figures. C. A. A., G. J. M., M. T., G. B. and M. D. K. critically revised the manuscript. All authors had full access to all the data of the study and approved the final version of the manuscript.
There are no conflicts of interest.
Supplementary material
To view supplementary material for this article, please visit https://doi.org/10.1017/S000711452200068X
Open access
